Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory Damage by Uderhardt, S. et al.
Article
Resident Macrophages Cloak Tissue Microlesions to
Prevent Neutrophil-Driven Inflammatory DamageGraphical AbstractHighlightsd Resident tissue macrophages (RTMs) respond to tissue
damage and cloak the debris
d Cloaking by RTM prevents neutrophil activation and
neutrophil-driven inflammation
d Cloaking by RTM prevents excess tissue damage and
preserves tissue homeostasisUderhardt et al., 2019, Cell 177, 541–555
April 18, 2019 Published by Elsevier Inc.
https://doi.org/10.1016/j.cell.2019.02.028Authors
Stefan Uderhardt, Andrew J. Martins,






In order to maintain homeostasis, tissue-
resident macrophages surround and hide
very small tissue lesions to prevent
excess inflammation driven by
neutrophils.
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Neutrophils are attracted to and generate dense
swarms at sites of cell damage in diverse tissues,
often extending the local disruption of organ archi-
tecture produced by the initial insult. Whether the in-
flammatory damage resulting from such neutrophil
accumulation is an inescapable consequence of
parenchymal cell death has not been explored. Using
a combination of dynamic intravital imaging and
confocal multiplex microscopy, we report here that
tissue-resident macrophages rapidly sense the
death of individual cells and extend membrane pro-
cesses that sequester the damage, a process that
prevents initiation of the feedforward chemoattrac-
tant signaling cascade that results in neutrophil
swarms. Through this ‘‘cloaking’’ mechanism, the
resident macrophages prevent neutrophil-mediated
inflammatory damage, maintaining tissue homeosta-
sis in the face of local cell injury that occurs on a reg-
ular basis inmany organs because ofmechanical and
other stresses.
INTRODUCTION
Inflammation is a multicellular host response to infectious or
physical tissue damage involving a complex, tightly orchestrated
sequence of events. It begins with an initiation phase at the onset
of infection or sterile cell injury during which chemoattractant
signals promote immune cell recruitment, followed by propaga-
tion and enhancement of the initial hematopoietic cell response,
and ending with the eventual resolution of the lesion through
clearance of the inflammatory cells and repair of the underlying
tissue damage. The latter resolution event may take place with
or without scarring that can disrupt optimal tissue homeostasis
and function (Medzhitov, 2008). Neutrophils and recruited cells
of the mononuclear phagocyte system (MPS) play pivotal roles
in this sequence of events, dominating the early infiltrate and
providing a critical, fast-acting layer of innate defense.Inflammation, however, is not always beneficial to the host.
Innate immune cell activation, particularly neutrophil function,
is a contributing factor to different aspects of disease pathology
(e.g., myocardial infarction, pneumonia) in both rodents and hu-
mans (Nicola´s-A´vila et al., 2017; Rock et al., 2010; Weiss, 1989).
The powerful weaponry neutrophils possess to combat patho-
gens can cause substantial collateral damage, which then am-
plifies further immune cell activation, loss of functional tissue,
and eventual organ dysfunction (Brandes et al., 2013). The ca-
pacity of the innate immune cellular response to increase tissue
damage beyond that created by the inciting infection or lesion it-
self suggests that early checkpoints controlling the inflammatory
response must be in place to counter unnecessary recruitment
and secondary damage mediated by these effector cells. How-
ever, what such checkpoints might be and whether they operate
merely to attenuate the magnitude or duration of otherwise
typical neutrophil infiltration responses or might actually prevent
such potentially tissue-damaging actions of the innate immune
system remain largely unknown.
Among the cells likely to play a central role in such putative
regulatory activities are cells of the MPS. Macrophage transcrip-
tional signatures are common in tissue samples from individuals
or experimental animals with variety of disease processes (Mur-
ray, 2017; Wynn et al., 2013). The MPS is comprised of macro-
phages resident in all tissues as well as migratory monocytes,
which primarily circulate in the bloodstream and infiltrate tissues
upon initiation of the inflammatory cascade, where they can
become definitive macrophages (Geissmann et al., 2010). Fate
mapping studies have revealed a strong development compo-
nent of this dichotomy: most resident tissue macrophages
(RTMs) are primarily of prenatal origin (yolk sac or fetal liver),
whereas monocytes are continuously produced by definitive
post-natal hematopoiesis (Ginhoux and Guilliams, 2016). De-
fects in the RTM compartment are often associated with devel-
opmental disorders and disruptions of physiological tissue
equilibrium states (Gordon and Martinez-Pomares, 2017; Okabe
and Medzhitov, 2016), highlighting the homeostatic functions
executed by these macrophages, whereas circulating mono-
cytes have long been implicated in the various aspects of the in-
flammatory cascade (Murray, 2018). However, how RTMs other
than brain microglial cells directly respond to tissue damage hasCell 177, 541–555, April 18, 2019 Published by Elsevier Inc. 541
Figure 1. Endogenous Neutrophils Fail to Swarm at Microlesions
(A) Pre-recruited neutrophils (magenta) swarming at a macrolesion (gray). Scale bar, 30 mm. Representative of 3 experiments. See also Video S2B.
(B) Leading neutrophils (magenta) undergo cell death (cyan outline) upon contact (*) with the macrolesion (gray) and initiate swarming. Scale bar, 10 mm. See also
Video S2C.
(C) Distance-time plot of individual tracks of pre-recruited neutrophils migrating toward a macrolesion (bottom of the graph). Track color, chemotactic index; (X),
neutrophil death; #, swarming. Representative of 3 experiments. See also Figure S1H.
(D) Changes in injury size (top, gray) and collagen structure (bottom) at amacrolesionwith pre-recruited neutrophils over time. Scale bar, 30 mm. Representative of
2 experiments. See also Video S2E.
(legend continued on next page)
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not been carefully explored, despite the probable contribution of
such cells to the regulation of local inflammatory responses
(Medzhitov, 2008).
In this study, we use high-resolution intravital as well as static
multi-parameter in situ imaging techniques to examine the very
early stages of inflammatory responses to sterile tissue damage.
We identified a regulatory mechanism that involves tissue-
sessile, interstitial RTMs acting as very local, dynamic first
responders to small-scale (single-cell) tissue damage. By phys-
ically sequestering or ‘‘cloaking’’ pro-inflammatory debris, the
RTMs actively prevented initiation of a previously defined neutro-
phil recruitment and swarming cascade (La¨mmermann et al.,
2013), disrupting potential tissue-damaging inflammatory
responses at the earliest possible stage. Failure of the RTM-
mediated cloaking process led to unchecked local inflammatory
responses, neutrophil swarms, and collateral tissue damage that
required secondary containment of neutrophil-driven inflamma-
tion by recruited migratory monocytes. Thus, by cloaking tissue
lesions, RTM set a tissue-specific critical threshold for innate
immune cell activation, constituting a previously unrecognized
immune checkpoint involving active prevention of steady-state
inflammatory damage.
RESULTS
Endogenous Neutrophils Fail to Swarm at Microlesions
Neutrophil congregation is a key feature of most peripheral in-
flammatory responses and follows distinctive dynamic patterns
described as neutrophil swarming, which comprises the recruit-
ment and collective directed movement of inflammatory neutro-
phils toward a focus in response to the prior activation of one or
more ‘‘leading’’ neutrophils (La¨mmermann et al., 2013; Ng
et al., 2011). To study regulatory pathways orchestrating this
activation in greater detail in vivo, we developed an intravital
imaging platform involving the peritoneal wall (Figure S1A;
Video S1A). The peritoneal serosa provided a useful site with
a clear anatomical structure (Figure S1B; Video S1B) along
with minimal optical and physical barriers, enabling in-depth,
high-resolution imaging of inflammation and cell recruitment
kinetics. This model also permitted topical application of
small-molecule inhibitors or antibodies for in situ labeling of
cells (Figures S1C and S1D).
To record extravascular neutrophil dynamics, we topically
applied chemokines to attract neutrophils into the peritoneum,
leading to accumulation within 40–60 min. As expected, neutro-
phils displayed strong swarming behavior in response to both(E) Pre-recruited neutrophils (magenta) swarming at a macrolesion (top) or a micr
Video S2G.
(F) Changes in injury size (top, gray) and collagen structure (bottom) at a microlesio
3 experiments. See also Video S2H.
(G) Swarming behavior of endogenously recruited neutrophils (magenta) at a ma
Video S2I.
(H) Individual tracks of pre-recruited (top) versus endogenously recruited neutro
experiments. See also Video S2J.
(I) Distance-time plot of tracks of pre-recruited (left) versus endogenously recruite
index; (X), neutrophil death; #, swarming; *, wandering behavior. See Figure S1H
See Video S2J.pathogens (Figure S1E; Video S2A) and sterile laser-induced
damage (Figure 1A; Video S2B). In both cases, cells followed
sequential activation patterns (Videos S2C and S2D); the neu-
trophils first approaching the damage site displayed explor-
atory movements (Figure 1B), followed by one or more of the
cells undergoing terminal activation upon direct contact with
the debris. This event was marked by distinct morphological
changes and nuclear uptake of propidium iodide, consistent
with cell death (Figure 1B; Figures S1F and S1G). This activa-
tion was subsequently followed by the attraction of a large
number of activated neutrophils, which now directly targeted
the damage, migrating in a very directed manner from many
cell diameters away from the lesion site and displaying clear
swarming behavior at the site of damage (Figures 1B and 1C;
Figures S1G–S1I). Examining the site of neutrophil swarming
using auto-fluorescence and second harmonic signals over
time revealed the destructive potential of this process. The re-
cruited and aggregating neutrophils broke down the coagu-
lated tissue but also expanded the primary damage to initially
unaffected healthy tissue with disruption and partial destruction
of collagen fibers. The result was substantial local collateral tis-
sue damage because of the swarming response (Figure 1D;
Video S2E). These features were all consistent with prior
studies in a sterile injury model in mouse ear skin (La¨mmer-
mann et al., 2013).
Given the damage imposed by neutrophil responses to cell
injury, we asked whether there existed discriminatory thresh-
olds for neutrophil activation that would prevent such undesir-
able responses by impeding unnecessary swarming. In partic-
ular, we considered whether the accidental, non-apoptotic
death of single cells, which might well be a frequent event in
various tissue sites because of mechanical or other stresses
(e.g., in muscles or at pleural or visceral serosal surfaces), could
be prevented from routinely eliciting an inflammatory response
that might contribute to progressive organ injury. To simulate
such individual necrotic cell death, we scaled down the size of
the laser-induced lesion to the single-cell level (microlesion; Fig-
ures S2A–S2D). In an initial series of experiments, we used che-
moattractants to pre-elicit neutrophil migration into the tissue so
that they were present at the time the stromal lesion was initi-
ated by the laser pulse. Such extravascular neutrophils engaged
in direct contact with the exposed debris (Figures S2E and S2F;
Data S1), displaying the same terminal activation patterns (Fig-
ure S2G; Video S2F) and subsequent swarming dynamics at mi-
crolesions (Figure 1E, top) as seenwithmacrolesions (Figure 1E,
bottom; Figure S2H; Video S2G). Likewise, such swarming at aolesion (bottom). Scale bar, 30 mm. Representative of 4 experiments. See also
n with pre-recruited neutrophils over time. Scale bar, 30 mm. Representative of
crolesion (gray). Scale bar, 50 mm. Representative of 2 experiments. See also
phils (bottom) at microlesions (outline). Scale bar, 20 mm. Representative of 3
d (right) neutrophils migrating toward a microlesion. Track color, chemotactic
. Representative of 3 experiments.
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microlesion eventually resulted in similar collateral damage to
cellular and acellular stromal components of the tissue (Fig-
ure 1F; Figure S2I; Video S2H). Extravascular neutrophils able
to rapidly access cell debris thus appeared to respond in an
all-or-nothing fashion, showing similar swarming dynamics at
both macro- and microlesions.
A fundamental mechanistic concept of swarming is the
secretion of secondary mediators (e.g., LTB4) by activated
neutrophils, which act in a signaling relay mode to promote
recruitment of inflammatory cells over longer distances within
the tissue (Afonso et al., 2012; La¨mmermann et al., 2013). We
thus sought to study not only the behavior of pre-elicited neu-
trophils but to adapt our experimental setup to capture the
endogenous response to the damage. Induction of a macrole-
sion in naive, untreated tissue reliably drove recruitment of
neutrophils within the first hour, showing delayed but similar
terminal activation patterns and swarming as seen with
pre-elicited neutrophils (Figure 1G; Video S2I). However,
compared with the dynamics of pre-recruited neutrophils (Fig-
ure 1H, top), the endogenous response at small microlesions
differed considerably (Figure 1H, bottom; Video S2J): Neutro-
phils were still attracted to the site of damage but mostly
displayed exploratory wandering movements and failed to un-
dergo terminal inflammatory activation or induce swarming
(Figure 1I; Figure S2J).
Resident Tissue Macrophages Cloak Tissue
Microlesions
To understand why endogenously recruited neutrophils, in
contrast to pre-elicited extravascular neutrophils, failed to
swarm at microlesions, we investigated the dynamic behavior
of other cells in the tissue. Embedded among fibroblasts, we
found a large population of evenly distributed RTMs (Figure 2A;
Figure S3A; Data S2A) that were non-migratory but whose
cellular processes exhibited a continuous sampling and endocy-
tosis behavior (Figure S3B; Video S3A). Within 1–3 min of
damage induction, however, RTMs quickly sent out multiple
spreading pseudopods toward the lesion while still remaining
sessile and fixed in position with respect to the main cell body
(Figure 2B; Video S3B).
This early dynamic response was observed in RTMs within a
radius of 100–150 mm around the lesion (‘‘sensing’’). Pseudo-
pods originating from RTMs within 50–100 mm eventually closed
in on the outer perimeter of microlesions (‘‘convergence’’; Fig-
ure 2C), whereas cells further away retracted the initial probing
pseudopods and continued with regular sampling dynamics.
This divided the tissue and localized RTMs into an inner and an
outer response zone around the damage. Being numerically
restricted as well as sessile with a limited radius of action, this
dynamic macrophage response was far more effective at
covering microlesions, where pseudopods were able to cloak
all or nearly all of the visible damage (Figure 2C; Video S3C;
Data S2B) compared with larger regions of injury (Figure 2D).
Together with the surrounding immobile stromal cells bodies,
the cloaking processes covered the exposed part of the micro-
lesion almost completely, rendering the damage functionally
inaccessible to probing neutrophils (Figures 2E and 2F; Data
S2C and S2D).544 Cell 177, 541–555, April 18, 2019At the site of lesion cloaking, large vesicles emerged, indi-
cating enhanced endocytic activity of the responding RTM
(Figure 2G). This suggested that cloaking might physically
sequester the damage away from subsequently arriving neutro-
phils while also scavenging damage-associatedmolecular prod-
ucts (DAMPs) released from the injured or dead cells (Uderhardt
et al., 2012). Together, this inhibition of damage sensing ap-
peared to prevent the activation and propagation of the leuko-
triene-dominated feedforward recruitment sequence that is
necessary for swarming (La¨mmermann et al., 2013).
Cloaking Prevents Neutrophil-Driven Inflammation
To test directly whether RTM cloaking actively prevents swarm-
ing, we took advantage of the fact that several RTM populations
selectively express the lectin CD169 and can thus be reliably
distinguished from monocytes and neutrophils (Figure S3C).
The CD169-diptheria toxin receptor (DTR) mouse model allowed
us to specifically deplete RTMs in the peritoneum using diph-
theria toxin (DT) without affecting other relevant phagocyte pop-
ulations (Figures S3D–S3F).
RTM depletion in CD169-DTRmice had no effect on the timing
or extent of neutrophil recruitment, activation, and subsequent
swarming at macrolesions, with comparable infiltrates within
the first hours in control and DT-treated animals (Figure 3A).
Similar results were obtained with a model of acute peritonitis
(Figure S3G). These results indicated that CD169-expressing
RTMs were not acting as sentinels of sterile insult but were
dispensable for the initiation of an inflammatory response to
macroscopic damage. In contrast, RTM depletion dramatically
changed the inflammatory dynamics at a microlesion. In
CD169-DTR mice treated with DT to deplete the RTM and pre-
vent cloaking, the leading neutrophils made extensive contact
with the debris, underwent terminal activation, and induced
swarming (Figures 3B and 3C; Video S4A;) with typical inflamma-
tory dynamic patterns (Figure 3D; Figure S3H). These findings
showed that RTMs were able to prevent neutrophil swarming
at microlesions but not at macrolesions.
Quantitative Limitations to Cloaking Efficiency
Given their numeric and spatial limitations, we speculated that
RTM cloaking would fail not only when the macrophages were
confronted with large-scale damage (macrolesions) but also
when challenged with multiple microlesions at once. Indeed,
two sequential microlesions set close to each other after enough
time for the initial damage to begin the RTM response process
allowed only the first lesion to be sufficiently cloaked, whereas
the latter remained highly exposed. Neutrophils recruited to the
uncloaked second site of damage became activated and initi-
ated swarming, whereas the initial cloaked lesion remained
free of inflammation (Figure 3E; Figures S3I and S3J; Video
S4B). These observations indicate that RTMs do not provide a
large-scale diffusive barrier to neutrophil activation in the tissue
but act very locally to constrain neutrophil responses within the
confines of their extended cellular processes at the site of tissue
damage and that this response system has evolved to deal with
only very limited cell damage in a local region at any time.
When substantially depleted in a post-natal host, RTMs can be
replaced by monocyte precursors. The replacement cells adopt
Figure 2. Resident Tissue Macrophages Are Dynamic First Responders to Tissue Damage
(A) Peritoneal serosa (top) and close-up image of an RTM (bottom) under resting conditions. Scale bars, 5 mm (top) and 50 mm (bottom). See also Video S3A.
(B) First minutes of an individual RTM (green) responding to a sterile tissue injury (bottom, data not shown). Scale bar, 10 mm. See also Video S3B.
(C) RTMs (green) responding to a microlesion (gray). Image 4 shows image 3 at higher magnification. Circles indicate the inner (red) and outer (cyan) response
zone around the damage. Scale bars, 20 mm (1–3) and 10 mm (4). See also Video S3C.
(D) Different magnifications of RTMs (green) responding to a macrolesion (gray). Scale bars, 20 mm (left) and 10 mm (right).
(E) Cloaking RTMs and stromal cells covering a microlesion. Shown are a maximum intensity projection (left) and a 3D surface model (right). See also Data S2C.
Scale bar, 20 mm. A dashed cross marks the cross-section in (F). Representative of more than 5 experiments.
(F) Planar cross-sections of the 3D object in (E). See also Data S2D. Scale bar, 20 mm.
(G) Large endosomes (arrows) in a cloaking RTM (green) at a microlesion (orange). Scale bar, 5 mm.much of the tissue-specific transcriptional profile of prenatally
derived RTMs over the course of several weeks, although the
replacement cells do differ in some respects from the normal
RTMs; whether they perform an equivalent function as their
pre-natal predecessors remains unclear (Ginhoux and Guilliams,
2016). We therefore used a LysM-Cre x Csf1r-DTR model to
deplete monocytes and RTMs by short-term DT treatment
(Schreiber et al., 2013; Figures S3E and S3F), followed by adop-
tive transfer of donor bone marrow cells (Figures S3K and S3L).
This produced an animal with repopulation of host monocytes
and new RTMs, creating a chimera of host- and donor-derived
macrophages in the tissue (FigureS3M).DT re-treatment 8weekslater (Figure S3N) specifically depleted host DTR-positivemacro-
phages without affecting donor-derived DTR-negative RTMs,
creating RTM-rich and RTM-depleted areas within the same tis-
sue, as indicated by dextran uptake (Figure S3O). As expected,
donor-derived RTMs readily cloakedmicrolesions in their vicinity
(Figure 3F), whereas uncloaked lesions in RTM-depleted areas
readily caused neutrophil swarming and inflammation (Figures
3F and 3G). Taken together with the multiple lesion study, these
results reveal that spatial organization and lesion density, not
just size, dictate the effectiveness of RTM cloaking in response
to sterile damage, rendering the inhibitory processmost effective
at widely spaced, individual microlesions (Figure S3P).Cell 177, 541–555, April 18, 2019 545
Figure 3. Cloaking by RTMs Prevents Neutrophil Activation and Subsequent Swarming
(A) RTMs (green) and neutrophils (magenta) responding to macrolesions (gray) in CD169-DTR mice treated with vehicle (top, blue graph) or DT (bottom, red
graph). Scale bar, 30 mm.Graphs show infiltrate volumes (means ±SEMas dashed lines) over time. Bottom pictures show surface volume renderings of infiltrates.
n = 4 animals per group.
(B) RTMs (green) and neutrophils (magenta) responding to microlesions (gray) in CD169-DTR mice treated with vehicle (top) or DT (bottom). Scale bar, 30 mm.
n = 5 animals per group. See also Video S4A.
(C) Frequencies of neutrophil swarming (magenta) versus successful cloaking by RTMs (no swarming, green) at microlesions in vehicle-treated (left) or DT-treated
(right) CD196-DTR mice. Two-way ANOVA; n = 5 animals per group with 5–7 microlesions per mouse; means ± SEM.
(D) Top: Distance-time plot showing tracks of pre-recruited neutrophils migrating toward amacrolesion (top left) or microlesion (top right). Bottom: Distance-time
plot showing individual tracks of endogenously recruited neutrophils migrating toward a microlesion in vehicle-treated (bottom left) or DT-treated (right) CD169-
DTR mice. (X), neutrophil death; #, swarming; *, wandering behavior. See also Figure S1H.
(E) RTMs (green) and neutrophils (green and magenta) responding to two sequential microlesions (gray) set close to each other at minute 0 (left lesion 1) and at
minute 20 (right lesion 2). Scale bar, 20 mm. Representative of 3 experiments. See also Video S4B.
(F) RTMs (green) and neutrophils (magenta) responding to two microlesions set simultaneously in an RTM-rich (left lesion) or RTM-lacking (right lesion) area in
partially RTM-depleted mice. Scale bar, 30 mm. Representative of 3 experiments with 3 sets of lesions per mouse. See also Figures S3K–S3O.
(G) Frequency of neutrophil swarm initiations in RTM-rich (WT) versus RTM-depleted (depl.) areas within the same field of view (F). Unpaired t test; n = 3 animals
per group with 3 microlesion sets per mouse; means ± SEM.
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Figure 4. Sequential Sensing of Damage-Associated Alarmins Drives Cloaking
(A) Mean square displacement of individual RTM pseudopods moving toward a microlesion over time. Data were pooled from three independent tracking ex-
periments. See also Figures S4A and S4B.
(B) P2 receptor expression in different phagocyte populations isolated from peritoneal tissues of Cx3cr1gfp/+Ccr2rfp/+ mice (n = 3). Normalized transcripts per
kilobase million; means ± SEM.
(C) RTM (green) responses 30 min after damage induction (orange) in mice pre-treated with vehicle (top), apyrase (center), or suramin and 2050-isomeric pyr-
idoxalphosphate-6-azophenyl-2’,50-disulfonic acid (iso-PPADS; bottom). n = 3–5 animals per group with 2–3 lesions per mouse. Scale bar, 15 mm. White circles
mark uncloaked areas.
(D) Comparison of RTMcloaking capacities upon inhibitor treatment. n = 2–3 animals per groupwith 2–3 lesions permouse. One-way ANOVA; each condition was
compared to the naive control; means ± SEM.
(E) RTM (green) responses 30 min after damage (orange) induction in mice treated with vehicle (top), pertussis toxin (PT; center), or FPS-ZM1 (bottom). n = 3–5
animals per group with 2–3 lesions per mouse. Scale bar, 15 mm.
(legend continued on next page)
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Sequential Sensing of Damage-Associated Alarmins
Drives Cloaking
Dynamic tracking of individual RTM pseudopods from the inner
and outer zone around the lesion suggested a biphasic kinetic
during the cloaking response, comprising an initial sensing
phase (inner and outer zone) and a subsequent convergence
process (Figures 4A and 2C; Figures S4A and 4B). Nucleotides
act as short-range activators of innate immune cells and are
among the earliest intracellular molecules released from
damaged cells (Ve´ne´reau et al., 2015). Transcriptional analysis
of RTMs revealed the expression of multiple receptors capable
of sensing different nucleoside di- and/or triphosphates (Fig-
ure 4B). Removing extracellular nucleotides locally with apyrase
almost completely blocked early RTM activation in response
to damage and severely impaired cloaking of microlesions
(Figure 4C). Targeting specific nucleotide receptors or receptor
classes individually failed to interfere with cloaking, and only
blocking nucleotide sensing entirely could replicate the apyrase
effect, which suggested a high level of receptor signaling redun-
dancy (Figures 4C and 4D).
Given the short half-life and range of extracellular nucleotides,
we further speculated that other DAMPs could be involved in the
full cloaking response. Pre-treatment of RTMs with pertussis
toxin (PT) did not interfere with initial lesion sensing but pre-
vented the extending pseudopods from making contact with
the damage, pointing to a contribution of G protein-mediated
signaling during the convergence phase (Figures 4E and 4F; Fig-
ure S4B). The receptor for advanced glycation end products
(RAGE) is expressed in numerous immune and non-immune
cell populations, promiscuously senses a plethora of different
alarmins like various advanced glycation end products (AGEs),
S100 family proteins, and the chromatin protein HMGB1, and
operates in a predominantly PT-sensitive manner (Degryse
et al., 2001). By blocking RAGE with two different pharmacolog-
ical inhibitors as well as using RAGE knockout mice (Constien
et al., 2001), we could indeed phenocopy the effect of PT on
the convergence phase of cloaking without affecting initial
sensing (Figures 4E–4G; Figure S4C).
Global RAGE deficiency also affects inflammatory activation
of neutrophils (Huebener et al., 2015). We therefore adoptively
transferred wild-type and RAGE/.EGFP bone marrow into
monocyte and macrophage-depleted hosts to specifically study
the effect of RAGE deficiency on the cloaking ability of RTMs
(Figure S4D). Taking advantage of the non-random chimerism
of host- and donor-derived RTMs 8 weeks after transfer, we
induced microlesions in areas enriched with RAGE/ or wild-
type (WT) cells (Figure 4H) and directly compared their cloaking(F) Mean square displacement of individual RTM pseudopods moving toward a m
toxin (purple) and RAGE/ (cyan) mice over time. Data were pooled from three ind
SEM. See also Figure S4C.
(G) Distances of pseudopods to microlesions (left) and physically cloaked area (
induction in WT mice treated with vehicle (blue), apyrase (yellow), PT (purple), FPS
Two-way ANOVA; means ± SEM. See also Figure S4C.
(H) Responses of wild-type RTMs (green) versus RAGE/.EGFP RTMs (cyan)
behavior (magenta). See also Figure S4D. Scale bar, 100 mm. Representative of
(I) Frequency of neutrophil swarm initiations in wild-type (WT) versus RAGE-defici
per mouse; means ± SEM.
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sponses, similar to what we observed with pharmacologic inhibi-
tion (Figure 4H), eventually permitting infiltrating neutrophils to
make physical contact with the debris and initiate swarm forma-
tion (Figures 4H and 4I). These data indicated that activation of
RTMs in response to sterile tissue damage was initiated by
nucleotide-induced signaling, whereas sensing of secondary
alarmins was necessary for pseudopod extensions to complete
the cloaking process.
Late-Stage Events in LesionResolutionwith andwithout
RTM Cloaking
To investigate the longer-term consequences on tissue homeo-
stasis when cloaking is absent, we established an experimental
system that allowed us to follow and re-image the same micro-
lesions over time, using prominent deep vessel patterns to
map the damage site (Figure 5A). 22 h after microlesion wound-
ing, we consistently failed to detect neutrophil swarms in control
mice (Figure 5B, left), with most of the microlesions having either
vanished or markedly shrunk in size (Figure 5C). Conversely,
RTM depletion in CD169-DTRmice reliably caused inflammatory
swarming at microlesions that were still evident 22 h later
(Figure 5B, bottom right), with most lesions increasing in size
(Figure 5C) and showing enhanced collagen displacement (Fig-
ure 5D). This indicated that lack of RTM allowed not only neutro-
phil-driven inflammation at microlesions but also affected
healthy tissue by causing collateral damage. Cloaking, in turn,
promoted healing of the microwounds in a non-phlogistic
manner.
Failure of Cloaking RequiresMonocyte Recruitment and
Secondary Containment
Failure of cloaking to prevent neutrophil activation at macrole-
sions led to recruitment of CCR2+ and CX3CR1+ monocytes
2–4 h later (Figure S4E). Monocytes present in the tissue under
steady-state conditions were migratory (Jakubzick et al., 2013)
but not primarily attracted to the damage (Figure S4F; Video
S5A). Instead, in the presence of swarming neutrophils, tissue-
patrolling and recruited monocytes formed a spherical structure
around the expanding focus (Figure 5E, top; Video S5B; Dal-
Secco et al., 2015; La¨mmermann et al., 2013), which coincided
temporally with the cessation of neutrophil recruitment (Fig-
ure S4E). Systemic depletion of neutrophils abrogatedmonocyte
attraction (Figure 5E, bottom; Video S5B), indicating that mono-
cytes were responding to the swarming neutrophils and not the
tissue damage per se. These findings suggest that, if cloaking
fails to prevent swarming, then recruited monocytes may noticrolesion in WT mice treated with vehicle (blue), FPS-ZM1 (red), or pertussis
ependent tracking experiments for each condition. Two-way ANOVA;means ±
right; pooled data from three independent experiments) 30 min after damage
-ZM1 (red) or RAGE antagonist peptide (RAP; green), or RAGE/ (cyan) mice.
to simultaneously induced microlesions (orange) and subsequent neutrophil
3 experiments with 3 sets of lesions per mouse.
ent (RAGE/) areas. Unpaired t test; n = 3 animals per group with 3 lesion sets
Figure 5. Failure of Cloaking Causes Collat-
eral Damage and Requires Containment by
Migratory Monocytes
(A) Vessel structure was used as a reference point to
map microlesions and re-image them 22 h later.
Scale bar, 30 mm.
(B) RTM (green) and endogenous neutrophil re-
sponses (magenta) to microlesions (gray) right after
damage induction and 22 h later in CD169-DTR
mice treated with vehicle (left) or DT (right). Arrows
show late microlesions. Representative of 2 exper-
iments. Scale bar, 20 mm.
(C) Size changes of individualmicrolesions over time
in vehicle-treated (left) or DT-treated (right) CD169-
DTR mice over time. Wilcoxon test on matched
samples (n = 5–7). Representative of 2 experiments.
(D) Collagen displacement at microlesions over time
in vehicle-treated (left) or DT-treated (right) CD169-
DTR mice over time. Wilcoxon test on matched
samples (n = 5–7 individual lesions). Representative
of two independent experiments. Images show
representative lesions in a DT-treated CD169-DTR
mouse right after damage induction (top, yellow
outline) and 22 h later (bottom, magenta outline).
Scale bar, 10 mm.
(E) Dynamic response of migratory CX3CR1+ (blue)
or CCR2+ (yellow) monocytes to a macrolesion in
isotype-treated (iso, top) or neutrophil-depleted
(aLy6G, bottom) Cx3cr1gfp/+Ccr2rfp/+ reporter mice.
Scale bar, 30 mm. Representative of 3 experiments
each.
See also Video S5B.only play a role in the later resolution of a lesion containing tissue
and neutrophil debris but may also limit unconstrained growth of
the neutrophil swarm and further tissue damage (Video S6).
RTM Cloak Partially Damaged Muscle Fibers
In situ immunostaining of various serosal and interstitial tissue
compartments revealed RTM populations with phenotypes and
highly organized distribution patterns, similar to what we
observed in the peritoneum (Figures 6A and 6B; Figures S5A–
S5C). Intravital imaging of tibialis anterior muscles further
showed that endo- and perimysial RTMs exhibited the same dy-
namic cloaking response to local necrotic tissue damage (Fig-
ure 6C) as seen in the peritoneal model. Dynamic imaging ofthe deeper abdominal muscles allowed
careful analysis of the cellular responses
after partially damaging a myocyte without
killing the entire myofiber (Figure S5D).
Such damage provoked a strong cloaking
response in the surrounding RTMs, which
sent out long processes to fully cover the
damaged area of the affected myofiber
(Figures 6D and 6E; Data S3). Although
partially damaging the myocyte caused
local swelling of the fiber, local loss of the
specific striated pattern, and the emer-
gence of longitudinal striation, it did not
result in complete myofiber death, withthe fiber managing to retain its structural integrity (Figure S5E).
Microlesions of myocytes in the presence of neutrophils, in
turn, readily induced swarming and inflammation, causing
further collateral damage and eventual rupture of the myofiber,
highlighting the destructive power of a swarm (Figure 6F; Fig-
ure S5F) and suggesting that regulation of neutrophil-driven
inflammation by RTMs could be a broadly relevant mechanism
of tissue protection across organs.
RTMsPrevent Excess Tissue Damage under Physiologic
and Diseased Conditions
To study the role of RTMs in a neutrophil-driven disease model,
we employed a genetic mouse model for muscle dystrophyCell 177, 541–555, April 18, 2019 549
Figure 6. RTM Cloak-Damaged Muscle Fibers
(A) Confocal images showing various RTM populations in naive LysM-gfp mice. Representative of 2 experiments. Scale bar, 30 mm.
(B) 3D reconstruction of RTM distribution in the tibialis anterior muscle. Object color, distance on the y axis. Scale bar, 30 mm.
(C) Endomysial RTMs (green) responding to a microlesion (gray) in the tibialis anterior muscle. Scale bar, 20 mm. Representative of 3 experiments.
(D) Endo- and perimysial RTMs (green) responding to a partially damaged myofiber (top, maximum intensity projection; bottom, 3D reconstruction). See also
Data S3A. Scale bar, 20 mm.
(E) Planar cross sections of the 3D object in (D). See also Data S3B. Scale bar, 20 mm.
(F) Pre-recruited neutrophils (magenta) swarming at a partially damaged myocyte (purple). Top, maximum intensity projection; bottom, single slice through the
plane of damage. Arrows show a ruptured myofiber. Scale bar, 50 mm. Representative of 3 experiments.(mdx) in which dystrophin deficiency leads to cellular instability,
consequent necrotic damage, and eventual cell death of muscle
fibers. This causes systemic but self-limiting inflammatory
myopathy in the first weeks of life, predominantly affecting tis-
sues subject to higher mechanical stress, like the tibialis anterior
muscles or the diaphragm (Sicinski et al., 1989; Tidball, 2005).
Although initially only isolated myocytes are affected in the
mdx model, neutrophils have been shown to play a pivotal role
in exacerbating the damage and promoting clinical disease
(Hodgetts et al., 2006). We hypothesized that, early in disease,
interstitial RTMs would respond to the isolated necrotic damage
and prevent local neutrophil activation. With progressing
disease, however, more necrotic events would accumulate,
eventually overwhelming the tissue-protective function of
RTMs, leading to neutrophil activation and inflammation.
Studying the diaphragms harvested from 14-day-old mdx
mice revealed the early appearance of cloaking formations550 Cell 177, 541–555, April 18, 2019in the absence of neutrophil clusters (Figure S5G), often
converging around local swelling of muscle fibers, similar to
what we observed when analyzing laser-induced myocyte dam-
age (Figure 7A; Figure S5E). More extensive and/or advanced
foci, in turn, displayed already established neutrophil-rich inflam-
matory responses (Figure 7A). Consistent with our predictions,
early depletion of RTMs after birth (using aCsfr1 treatment or
the CD169DTR mouse model; Figures S3E and S3F) resulted
in premature onset of disease at ages when mdx control litter-
mates were still mostly free of muscle damage (Figures 7B and
7C). Histologically, RTM depletion in both cases led to extensive
necrotic areas (Figure 7D) marked by increased neutrophil infil-
trates (Figure 7E; Figure S5H), detectable in diaphragms as early
as 16 days of age in RTM-depleted but not control animals
(Figures S5I and S5J). Neutrophils were clearly driving this exac-
erbation because we were able to significantly reduce muscle
necrosis in the diaphragm of mice lacking RTM by additional
Figure 7. RTM Cloak-Damaged Muscle Fibers
(A) Diaphragms isolated frommdxmice on day 14 of age. White arrows show damagedmuscle fibers with cloaking RTM processes. Representative of more than
3 experiments. Scale bar, 20 mm.
(B) Extent of necrosis in diaphragms of mdx mice on day 16 (left) or day 18 (right), treated with isotype (green), anti-CSFR1 (magenta), or anti-CSFR1 and anti-
Ly6G (blue). Unpaired t test (day 16); one-way ANOVA (day 18); n = 3–5 animals per group; means ± SEM. Representative of 2 experiments.
(C) Extent of necrosis in diaphragms of CD169+/+ (green) or CD169DTR/+ (magenta) mdxmice on day 16, treated with DT. Unpaired t test; n = 5 animals per group;
means ± SEM. Representative of 2 experiments.
(D) Diaphragms from CD169+/+ (left) or CD169DTR/+ (right) mdx mice on day 16, treated with DT. Arrows show necrotic tissues (orange to white). Scale bar,
1,000 mm.
(E) Neutrophil infiltrates (magenta) in necrotic muscle (blue). Scale bar, 50 mm.
(F) Representative confocal image of a Ce3D-cleared diaphragm; cloaking RTMs are highlighted in green. Scale bars, 500 mm (top) and 30 mm (bottom). See also
Video S7A.
(legend continued on next page)
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neutrophil depletion (Figure 7B; Figure S5K). RTMs thus
executed an early but limited tissue-protective function in
mdx mice.
We speculated that tissues subject to ongoing mechanical
stress would generally be at great risk for incidental cell damage
and would hence rely on tissue protection from RTMs in other-
wise healthy hosts. In support of this view, we could find cloak-
ing-like RTM constellations in peritoneal tissues of naive animals
(Figure S5L) as well as to an even greater extent in diaphragm
whole mounts (Figure 7F; Video S7A). Although rare at any
given time (5 events per diaphragm or 2 per peritoneum),
spontaneous cloaking clearly resembled experimentally induced
cloaking, with pseudopods converging around a central focus,
indicative of a damaged cell. In line with the notion that such
‘‘spontaneous’’ cloaking protects tissues from neutrophil dam-
age under steady-state conditions, long-term depletion of
RTMs in adult CD169-DTR mice led to the development of
necrotic myofibers in the diaphragm, associated with evidence
of scattered spontaneous inflammatory damage (Figures 7G
and 7H) dominated by inflammatory neutrophil infiltrates (Fig-
ure 7I; Figure S5M).
DISCUSSION
Although inflammatory responses are critical for host defense,
these responses can also cause extensive collateral tissue dam-
age and, hence, require strict regulation to avoid disruption of
organ function. Although great progress has been achieved in
deciphering anti-inflammatory pathways that curb propagation
of ongoing responses or orchestrate active resolution of such
processes (Fullerton and Gilroy, 2016), mechanisms that regu-
late and counter-balance the very earliest events involved in
the initiation of inflammation are less well defined. This study
was therefore designed to explore potential discriminatory
thresholds for inflammatory responses to cell damage or death
in vivo. Our findings provide strong evidence that tissues are
not routinely subjected to damaging inflammatory responses
by recruited effector cells should parenchymal cells die because
of local stresses but, rather, that the initiation of neutrophil-driven
inflammation is impeded through the local tissue-protective ac-
tions of sessile, tissue-resident macrophages.
Using our peritoneal imaging method, we observed rapid
sensing of cell damage by RTMs. This is similar to what has
been observed following sterile laser damage in the brain for
another population of RTMs, microglial cells (Davalos et al.,
2005). As in the present report, this response depended on
nucleotide stimulation of microglial cells, whereas the activity
of a limited nucleotide receptor set in the brain studies differed
from our findings (Haynes et al., 2006), in which global inhibition
of the P2X and P2Y families of receptors was necessary to
impede the damage-sensing mechanism. We also uncovered a
key role for additional signaling events in generating the mature(G) Diaphragms from adult CD169-DTR mice after long-term treatment with vehi
bar, 1,000 mm.
(H) Quantification of necrosis in diaphragms of CD169-DTRmice after long-term tr
group; means ± SEM. Representative of 2 experiments.
(I) Neutrophil infiltrates (magenta) in necrotic muscle (blue) in CD169-DTR mice a
552 Cell 177, 541–555, April 18, 2019cloaking response of peritoneal RTMs that involved the receptor
RAGE, which can respond to a variety of DAMPS such as
HMGB1 or various proteins of the S100 family (Liliensiek et al.,
2004). The secondary sensing by RAGE of material released
from the damaged parenchymal cell was necessary for nucleo-
tide-activated RTMs to fully extend processes toward and to
surround the injured or dead cell. The well-recognized role of
nucleotide receptors (Cekic and Linden, 2016) and RAGE (Hueb-
ener et al., 2015) in other myeloid cells, where they can play an
activating role that promotes inflammatory processes, makes it
impossible to study the long-term consequences of interference
with the cloaking response of RTM until animals can be engi-
neered to selectively lack the relevant receptors in only the
RTM population.
Beyond defining the ligands and receptors involved in evoking
the RTM cloaking response, our investigation goes further than
earlier studies to provide direct functional evidence for the
important role of this macrophage response in limiting inflamma-
tory damage in tissues under steady-state conditions. Selective
depletion of RTMs in CD169-DTR animals enabled microlesions
to induce neutrophil swarming responses that disrupted the local
cellular and stromal tissue environment. Analysis of perfused
fixed tissues revealed the presence of cloaking in naive, unchal-
lenged mice, suggesting a physiological role for this dynamic
process. Although a cloaking constellation persists only tempo-
rarily and, thus, is a rare event at any given time, the cumulative
effects of this process over time are substantial because
prolonged RTM depletion in the CD169-DTR model led to the
accumulation of necrotic myofibers in the diaphragm. This is
consistent with the concept that RTM cloaking acts in the steady
state to prevent neutrophilic tissue damage in response to death
of isolated cells because of mechanical and others stresses.
Further evidence of the key role of the RTM cloaking process
in limiting inflammatory tissue damage was obtained in a mouse
model of muscle dystrophy. Although monocyte-derived inflam-
matory macrophages have been implicated in later disease pro-
gression (Mojumdar et al., 2014), early depletion of RTMs using
two different approaches accelerated disease onset and severity
in association with earlier-than-normal accumulation of exten-
sive neutrophil infiltrates in neonatal muscles.
High-resolution dynamic imaging revealed the emergence of
large vesicles with centripetal movement in the pseudopods of
cloaking RTMs, indicative of increased endocytic activity and
the removal of debris and DAMPs. Neutrophils still appeared
around cloaked microlesions and showed migratory orientation
toward the damage, suggesting that the lesion was not ‘‘invis-
ible.’’ Because approaching neutrophils could be visualized
directly probing the cloaking processes rather than turning
away at a distance, the active secretion of chemorepulsive sig-
nals by cloaking RTMs seems unlikely but cannot be entirely
excluded. Furthermore, there was no evidence that cloaking
interfered with swarm progression (after its initiation); e.g.,cle (top) or DT (bottom). Arrows show necrotic tissues (orange to white). Scale
eatment with vehicle (green) or DT (magenta). Unpaired t test; n = 4 animals per
fter long-term DT-treatment. Scale bar, 100 mm.
through degradation of swarming mediators like LTB4, because
the absence of RTMs did not affect early swarm establishment.
The similarities of the cloaking process to descriptions of the
microglial response to laser-induced (Davalos et al., 2005) or Alz-
heimer’s disease-related neuronal damage (Jung et al., 2015)
raise the intriguing possibility that the sequestration of DAMPs,
as we describe here in preventing peripheral tissue neutrophil re-
sponses, might have a related function in limiting the spread of
inflammatory signals in the brain, albeit without neutrophil
swarming inhibition as a primary or the sole protective mecha-
nism. Moreover, one could speculate that the cloaking actions
of RTMs may limit recruitment of suppressive myeloid cells in
cancers, but the frequent death of transformed cells in growing
tumors might easily overwhelm this mechanism, leading to
the type of secondary cell recruitment noted here (Franklin
et al., 2014).
Swarm initiation is associated with the activation-associated
death of a leading neutrophil (La¨mmermann et al., 2013), and
we failed to find swarms being initiated without a leading neutro-
phil making physical contact with the lesion. Given the spatial ge-
ometry around a microlesion (Data S2 and S3), evidence that
neutrophils come close to the region of damage regardless of
the presence of cloaking (Data S1) and the necessity of the in-
flammatory death of a neutrophil to initiate swarming, we
conclude that a primary function of cloaking is acute blockade
of physical access to the debris, which renders cloaking a strictly
local event. Blocking access prevents contact-dependent acti-
vation, death of lead neutrophils, and initiation of the feedforward
molecular events that produce swarming and inflammation. In
turn, the more extensive the damage, the less likely it is for
RTMs to prevent neutrophil contact with the damage, consistent
with our experimental data. The role we reveal here for RTMs in
promoting tissue homeostasis and limiting cellular inflammation
in response to tissue injury has likely been obscured in prior
studies because RTMs are easily overwhelmed in common ani-
mal models of systemic inflammatory diseases or sterile injuries
by the large number of recruited cells or extent of primary dam-
age; e.g., ischemia or infarction models or skin punch or macro-
scopic needle injuries. We overcame this restriction by limiting
the inflammatory challenge to single-cell damage big enough
to induce a response but small enough to be contained by the
local regulatory mechanisms.
In most tissues, RTMs constitute a unique population of
mostly prenatally derived phagocytes. Early during organ devel-
opment, interstitial macrophages and stromal cells establish a
strong set of reciprocal interconnections that contributes to
establishment of an organ-specific pattern of cell distribution
and gene expression program in the local RTM population
(Amit et al., 2016; Gosselin et al., 2014; Mass et al., 2016; Okabe
and Medzhitov, 2014). Non-random RTM distribution patterns
ensure optimal coverage and surveillance for local tissue injury
with defects in RTM population density or spatial distribution,
compromising local cloaking capacity and giving attracted neu-
trophils a critical advantage. Perturbations of RTM population
maintenance or differentiation, genetically inherited variations
in RTM spatial distribution in tissues, as well as changes in
body habitus because of processes such as obesity that alter
the distribution pattern of these cells may lead to a propensityfor inflammatory tissue damage because of a failure of effective
cloaking when cell death occurs in tissue sites with sparse local
densities of RTMs. In addition, there is likely gradual replacement
of embryologically derived RTMs with monocyte-derived cells
during aging in certain tissues (Ensan et al., 2016; Molawi
et al., 2014). Further study of how the topography of RTMs and
the small but potentially meaningful differences in biology of
fetus versus adult-derived RTMs affects tissue homeostasis
may prove informative to better understand the well-studied in-
creases in measures of inflammation in the obese or elderly
and of idiopathic cumulative tissue damage in certain
individuals.
Although RTM are deeply embedded into the stromal fabric of
the tissue, migratory immune cells, such as monocytes and neu-
trophils, lack these intimate connections. The classical inflam-
matory cascade entails programs to restore rather than preserve
tissue homeostasis (Serhan and Savill, 2005). Migratory mono-
cytes populate peripheral tissues in meaningful numbers
(10%–15%of CD11b+ phagocytes in the peritoneum) (Jakubzick
et al., 2013). Although these monocytes did not primarily
respond to damage itself, they were readily attracted to ongoing
swarming activity and, together with additionally recruited
monocytes, encircled the expanding focus as described previ-
ously. This secondary sequestering of the focus appeared to
limit further neutrophil activation and recruitment and likely
initiated resolving and reparative programs (Arnold et al., 2007;
Dal-Secco et al., 2015). Therefore, although cooperatively tis-
sue-protective, both RTM and monocytes play different roles
in response to sterile tissue damage, primary prevention of
inflammation and secondary resolution, respectively (Fig-
ure S5N; Video S6).
In conclusion, our findings support a model in which RTMs
execute a tissue-protective role in response to acute micro-
scopic disruptions of stromal integrity, which can be further
understood as part of the pro-homeostatic core functions of tis-
sue macrophages, evolved to maintain tissue and organ
functionality. We speculate that tissues with limited regenerative
capacity critically depend on cloaking and that defects in RTM-
intrinsic cloaking factors, population dynamics, or cell distribu-
tion patterns could provoke immune responses to normally
subliminal homeostatic disruptions and contribute to the patho-
genesis of chronic inflammatory states and organ dysfunction.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals studies
The following mouse strains were used in this study:
d Lyz2gfp/gfp (‘‘LysM-gfp’’; C57BL/6-Lysozymetm1M-GFP; ‘‘LysM-gfp’’): NIAID repository, Taconic Farms, Cat#000342;
d Lyz2gfp/+: NIAID repository, Taconic Farms; Cat#008504.
d MaFIA (C57BL/6-Tg(Csf1r-EGFP-NGFR/FKBP1A/TNFRSF6)2Bck/J: The Jackson Laboratories; Cat#005070.
d hCD68-gfp (C57BL/6-Tg(CD68-EGFP)1Drg/J): The Jackson Laboratories; Cat#026827.
d Lyz2Cre/+ Csf1rDTR/+:
d F1 crossbreed: Lyz2Cre/Cre (‘‘LysM-cre’’; B6.129P2-Lyz2tm1(cre)Ifo/J; The Jackson Laboratories; Cat#004781) & Csf1rDTR/DTR
(C57BL/6-Tg(Csf1r-HBEGF/mCherry)1Mnz/J; The Jackson Laboratories; Cat#024046).
d Lyz2Cre/+ tdTomfl/+:
d F1 crossbreed: Lyz2Cre/Cre (B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J; The Jackson Laboratories; Cat#007914) &
tdTomfl/fl (B6N.129P2(B6)-Lyz2tm1(cre)Ifo/J; The Jackson Laboratories; Cat#018956)
d Siglec1DTR/+ mice (B6;129-Siglec1 < tm1(HBEGF)Mtka > ; Cat#RBRC04395; Miyake et al., 2007) were kindly provided by
Makoto Tanaka (Tokyo University, Japan) and distributed through Tracy McGaha (University of Toronto, Canada).
d Siglec1DTR/+LysZCre/Cre tdTomfl/fl
d Cx3cr1gfp/+ Ccr2rfp/+:
d F1 crossbreed: Cx3cr1gfp/gfp (C57BL/6-CD45a-[KO]CX3CR1-[KI]EGFP; Taconic Farms; Cat#008455) x Ccr2rfp/rfp (B6.129(Cg)-
Ccr2tm2.1Ifc/J; The Jackson Laboratories; Cat#017586).
d Dmdmdx (C57BL/10ScSn-Dmdmdx/J): The Jackson Laboratories; Cat#001801.
d DmdmdxLyz2Cre/+ tdTomfl/+ Siglec1DTR/+e3 Cell 177, 541–555.e1–e8, April 18, 2019
d Agertm1.1Arnd (RAGE knockout; RAGE/.eGFP) mice were kindly provided by Ann Marie Schmidt (NYU School of medicine,
USA). In this mouse line, successful deletion of the RAGE gene results in transcription of eGFP (Constien et al., 2001).
All mice were maintained in specific-pathogen-free conditions at an American Association for Laboratory Animal Care–accredited
animal facility at the NIAID (National Institute of Allergy and Infectious Diseases, NIH) andwere used under a study protocol approved
by NIAID Animal Care and Use Committee (National Institutes of Health, NIH). Mice from Taconic were obtained through a special
NIAID contract.
If not otherwise stated, all imaging experiments were performed with 8-12 weeks old mice, and both male and females were used
at equal ratios for the studies as they displayed similar immune cell dynamics in vivo.
METHODS DETAILS
Intravital imaging of the peritoneal serosa
See Figure S1A and Video S1A. Intravital imaging was performed on a Zeiss 710 microscope equipped with a femtosecond-pulsed
Chameleon laser (Coherent) and a 20x water immersion objective (NA 1.0, Zeiss). Animals were anesthetized with isoflurane (Baxter;
FORANE; Cat#1001936040). To expose the parietal peritoneal serosa, a midline incision of the abdominal skin and peritoneal wall
along the linea alba was performed. Using two small sutures (CP Medical; Monomid 5/0 Nylon; Cat#661B), the abdominal wall
was carefully laid down and mounted on an 8 3 10 mm plastic base plate using Vetbond (3M; Cat#1469SB). At this point,
5-10 mL of sterile pre-warmed buffer (150 mM NaCl, 3.0 mM K, 1.4 mM Ca, 0.8 mM Mg, 1.0 P, 155 mM Cl; all chemicals were pur-
chased from Sigma-Aldrich; pH 7.4; 34 C) with inhibitors/vehicles or antibodies were applied topically, before installing a sterilized
cover glass (Fisher Scientific; Cat# 12-545-80) flat on top of the exposed serosa. The animal was then transferred to the microscope
and kept in a heated imaging chamber. The heater was adjusted so that the serosa was kept at a constant temperature of 36 C.
Animals with damage and/or bleeding due to the surgery were not studied further. Epifluorescence was used to confirm the absence
of surgery-relatedmicroscopic trauma and to capture signs of premature inflammation such as vascular leakage or neutrophil rolling,
in which case the animals were also not used for further experiments.
If inhibitors and/or antibodies were used, an incubation time of 25-30 minutes was added before imaging session was started.
Without washing, basal macrophage dynamics were then recorded for 10 minutes prior to laser-induced damage to assess negative
effects of treatments on resting activity. Experiments were only continued if macrophages exhibited regular sampling dynamics.
Data were acquired at a resolution of 5123 512 (16 bit) in stacks of 12 frames each 3 mm apart at a frame rate of 968 ms using ZEN
software (Zen 2012; Zeiss). For imaging, the laser was tuned to 930 nmwith an output of ca. 80mWand the following filter cubeswere
used: FITC/GFP (565DCXR, 525/50; Zeiss), tdTomato/RFP (565DCXR, 575-640; Zeiss), SHG (495DCLP, 447/60; Zeiss). Raw imaging
data were processed and analyzed with Imaris (Bitplane). Three-dimensional tracking of cells or macrophage pseudopods was per-
formed using Imaris to generate spatial coordinates of individual objects over time. These data were further used to calculate track
displacements in Imaris or distance-time plots using a previously described open-source R script for graphic chemotaxis analysis
(La¨mmermann et al., 2013).
Sterile laser damage
Sterile, necrotic tissue damage was induced using laser pulses to produce lesions ranging from macrolesions (5x zoom with 20x
objective; brief (< 1 s.) two photon laser pulse at 1140 mW) to single-cell microlesions (35x zoom with 20x objective; brief
(< 1 s.) two photon laser pulse at 380 mW). See Figure S2D.
Macrolesion: 5x zoom; damage diameter > 60 mm; multicellular damage.
Microlesion: 35x zoom; damage diameter < 20 mm; partial-to-unicellular damage.
RTM dynamics were recorded immediately after the laser pulse for 30 minutes (cloaking dynamics), up to 5 hours (endogenous
neutrophil response) or up to 8 hours (endogenous monocyte recruitment). For inhibitor studies (Figure 4), 2-3 microlesions were
set each at least 1000 mmapart. For DTR/swarming studies (Figure 3) and long-term imaging experiments (Figure 5), 5-7microlesions
were set each at least 1000 mmapart and the occurrence of swarming versus successful cloaking was recorded. The brief laser pulse
coagulates the targeted tissue and causes an unmistakable, bright autofluorescence signal in virtually all imaging channels, which
can be recorded over time and used to demark the lesion. Detection of a second harmonic signal was used to identify collagen struc-
tures and superficial vessels.
The IVMcloaking experiments presented in this studywere performed using LysMgfp/gfp or LysMCre/+ tdTomfl/+mice. Similar results
were obtained using other fluorescent mouse strains such as LysMgfp/+, MaFIA, or hCD68-gfp mice (data not shown).
Intravital imaging of tibialis anterior muscles
A similar technical setup was used for intravital imaging of tibialis anterior muscles as for the peritoneal serosa. In brief, animals were
anesthetized with isoflurane, the left leg was immobilized, and a careful incision of the skin and subcutaneous tissues was performed
right above the tibialis anterior muscle compartment. The epimysial fascia was carefully removed, a sterilized cover glass was
installed, and imaging was performed as described above.Cell 177, 541–555.e1–e8, April 18, 2019 e4
Intravital imaging of deep abdominal muscle tissue
The same technical setup was used to image the muscular tissue of the abdominal wall as for the peritoneal serosa, except for the
imaging depth, which was around 60 – 100 mmbelow the peritoneal lining. Second harmonics signals were used to visualize collagen
and muscle fibers, which could readily be identified based on their characteristic striation.
In situ staining of neutrophils for IVM
Gr1-FITC (BioLegend; clone RB6-8C5; Cat#108405) was washed twice in buffer using 10 kDa centrifugal filters (Millipore; Amicon
Ultracel-10K; Cat#UFC501024) to remove BSA and sodium azide from the antibody solution. To label neutrophils in situ, ca.
0.5 mg of cleaned antibody in reconstituted in buffer was applied topically. Comparison of both neutrophil (andmacrophage) dynamic
behavior in the presence or absence of cleaned Gr1-FITC showed no observable difference (Figure S1C). Staining of neutrophils with
Ly6G-FITC (Biolegend; clone 1A8; Cat#127605) resulted in identical staining patterns (Figure S1D) but had substantially higher back-
ground fluorescence and seemed to interfere with immune cell dynamics.
Particle uptake studies
Mice were treated intravenously with 50 mg of each BSA-AF647 (ThermoFisher; Cat#A34785), 2000 kDa Dextran-Fluorescein
(Invitrogen; Cat#D7137), 70 kDa Dextran-Tetramethylrhodamine (Invitrogen; Cat#D1818) and 10 kDa Dextran-Cascade Blue (Invitro-
gen; Cat# D1976) diluted in 200 mL PBS. All dextrans used were lysine-fixable. Tissues were harvested 14 hours after injection and
processed for confocal microscopy as described below.
Inhibitor studies
Macrophages were topically pre-treated with following inhibitors at indicated concentrations:
d Apyrase (Sigma-Aldrich; Cat#A6535): H20; 10 U
d MRS2578 (Tocris; Cat#2146): DMSO; 10 mM
d PSB0739 (Tocris; Cat#3983): H20; 10 mM
d Suramin (Sigma-Aldrich; Cat#S2671): H20; 10 mM
d 5-BDBD (Tocris; Cat#3579): DMSO; 10 mM
d PSB12062 (Sigma-Aldrich; Cat#SML0753): DMSO; 10 mM
d A438079 (Sigma-Aldrich; Cat#A9736): DMSO; 100 mM
d JNJ 47965567 (Tocris; Cat#5299): DMSO; 100 mM
d iso-PPADS (Tocris; Cat#0683): H20; 100 mM
d oxATP (Sigma-Aldrich; Cat#A6779): H20; 50 mM
d BzATP (Sigma-Aldrich; Cat#B6396): H20; 50 mM
d FP-ZM1 (Tocris; Cat#6237): DMSO; 10 mM
d RAGE antagonist peptide (Tocris; Cat#6259): H20; 10 mM
d Pertussis toxin (Sigma-Aldrich; Cat#P7208): H20; 0.5 mg/ml
Animals were treated systemically (i.p.-injections) with following inhibitors:
d Clopidogrel (Sigma-Aldrich; Cat#C0614): DMSO; 1 mg/kg; 3 consecutive days.
All inhibitors were reconstituted according to the supplier’s instructions and diluted in pre-warmed buffer (see above). Topical
incubation volumewas kept at amaximum of 10 mL as we found that artificially increasing the interstitial volumewith buffer had nega-
tive effects on macrophage sampling and cloaking dynamics, likely due to dilution of local growth factors, electrolytes and released
DAMPs, respectively. After 20 minutes of incubation, intravital imaging was performed. Macrophage sampling behavior was re-
corded for 10 minutes, and experiments were only continued if cells displayed normal resting behavior.
2-3 micro-lesions were then induced as described above at a distance of at least 1000 mm between each other. The dynamic
response was recorded for 30 minutes after damage induction as most of the naive or vehicle-treated cloaking dynamic was
completed by that time. At least 3 animals were studied per group.
Survival surgery for long-term IVM
For long-term tracking of microlesions, vessel dyes (Dextran-Fluorescein 2000 kDa; Invitrogen; Cat#D7137) were used to identify
prominent deep vessel patterns, which functioned as guiding points to map microlesions on a relative x/y-coordinate system. After
damage-induction, the peritoneal cavity was closed using sutures and surgical clips, and the studied animals were allowed to
wake up and recover. 22 hours later, the same animals were subjected to a second, final intravital imaging session, in which
the deep vessels of the peritoneal wall were used to re-locate the lesions. At this time, Gr1-FITC was added to label infiltrating
neutrophils in situ.e5 Cell 177, 541–555.e1–e8, April 18, 2019
RTM depletion experiments with CD169-DTR mice
To deplete CD169-expressing RTM, CD169-DTR mice were intraperitoneally injected with vehicle or diphtheria toxin (DT; Sigma-
Aldrich; Cat#D0564) every other day for five days in total (10 ng/g body weight; 200 ng/d per mouse in 50 mL PBS).
Tissue macrophage replacement experiments
Please see Figure S3K for experimental outline. To deplete RTM, circulating monocytes and monocyte precursors, LysM-Cre/Csf1r-
DTR mice were treated with DT intraperitoneally for three days (10 ng/g body weight; 200 ng/day per mouse in 50 mL PBS). On the
second day of treatment, 5 3 106 unsorted bone marrow cells of indicated genotypes were adoptively transferred i.v. into macro-
phage/monocyte-depleted hosts. Eight weeks later, the reconstituted animals displayed a non-random chimerism of repopulating
host- and transferred donor-derived macrophages in the tissue, which generated host- or donor-rich areas, suitable to study the
cloaking response of different RTM populations within the same tissue (e.g., Figure 4H). This setup also permitted selective depletion
of the repopulating host-derived RTM (DTR-positive) by re-treating the animals with DT for three days before intravital imaging. In this
case, DTR-negative donor-derived RTM were not affected by the DT, thus creating RTM-rich and RTM-depleted areas within the
same tissue (Figure 3F). Where indicated, mice received dextran (10 kDa Dextran-Cascade Blue; ThermoFisher; Cat#D1976) i.v.
to label tissue macrophages and confirm depletion of host-RTM on the day prior to the experiment.
Muscle dystrophy model
Mdxmice carry amutation of the dystrophin gene (x-linked), which results in amildmyopathy startingwithin the first weeks after birth,
characterized by an accumulation of necrotic muscle fibers and inflammatory infiltrates that peak between day 21 and day 28 (Hodg-
etts et al., 2006). To evaluate the function of RTM prior to recruitment and infiltration of inflammatory cells, we thus focused on time
points in which naive mdx mice are still mostly free of disease (day 16) or start showing histological signs of disease onset (day 18).
To deplete macrophages, mdxmice were injected i.p. with vehicle or anti-CSFR1 antibodies (BioXCell; clone AFS98; Cat#BE0213)
starting on day 11 (dose 0.5mg) and repeated every other day (dose 0.25mg) until harvest on day 16 or day 18. To specifically deplete
CD169-expressing RTM in this model, mdx females were bred with CD169DTR/+LysMCre/CretdTomfl/fl males to generate DTR-positive
and -negative LysM-tomato male mdx pups (x-linked). All pups were treated i.p. with DT every other day (10 ng/g body weight) start-
ing at day 7 after birth until harvest on day 16. DTR-expression via PCR and sex was assessed post-mortem.
To deplete neutrophils, mice were additionally treated with anti-Ly6G antibodies (BioXCell; clone 1A8; Cat#BE0075-1) starting on
day 15 (dose 0.25 mg) and continued every other day until the end of the experiment on day 18.
One day prior to organ harvest, mice received an i.p. injection of 0.5% Evans blue solution (50 ml/g body weight; Tocris; Cat#0845).
On the day of harvest, animals were euthanized using CO2, tissues were collected, vigorously washed with PBS, fixed in 1% PFA
(EMS; Cat#15710) overnight at 4 C, and further processed for confocal microscopy. Necrotic areas were measured using Imaris
(Bitplane). 3-5 animals were studied per group and the experiments were repeated twice.
Peritonitis model
Mice were treated with 10 mg zymosan A (Sigma-Aldrich; Cat#Z4250) i.p. and peritoneal tissues harvested 12 hours later. Tissues
were fixed in 1%PFA overnight and then stainedwith anti-Ly6G (BioLegend; clone 1A8). Imaris spot functionwas used for automated
cell counting.
Immunofluorescence microscopy
Animals were euthanized with CO2. Shortly thereafter, transcardial perfusion with pre-warmed 4% PFA (EMS; Cat#15710) was per-
formed. Tissues were harvested and post-fixed with 12.5% BD Cytofix/Cytoperm ( = 0.5% formaldehyde; BD Bioscience;
Cat#554714) for 1h at RT. Whole tissues were permeabilized with BD Perm/Wash (BD Bioscience; Cat#554723) and stained in
BD Perm/Wash at RT overnight with following antibodies: CD34 PE (BioLegend; clone HM34) and CD169 A647 (BioLegend; clone
3D6.112).
Cell sorting and RNA-sequencing
One day prior to the experiment, Cx3cr1gfp/+Ccr2rfp/+ animals received an i.v. injection of 50 mg Dextran-Cascade Blue (Invitrogen;
Cat#D1976) to label interstitial phagocytes. On the day of the experiment, mice received 1 mg anti-CD45 (BioLegend; clone 30-F11)
intravenously 3minutes prior to euthanasia in order to label intravascular leukocytes. The peritoneal wall was then carefully removed,
spread out in a 6-well plate, and covered with 2.5 mL dissociation buffer: RPMI (GIBCO; Cat#11875093); 1% FBS (Gemini;
Lot#A20G001; Cat#100-106); 250 mg/ml Liberase TL (Sigma-Aldrich; Cat#5401020001); 100 mg/ml DNase II (Sigma-Aldrich; Cat#
D8764); 25 mM Z-VAD-FMK (Tocris; Cat#2163); 10 mM HEPES (GIBCO; Cat#15630080). After 20 minutes of incubation at 37 C,
dissociation was stopped with ice-cold FACS-buffer: PBS (GIBCO; Cat#10010-23; Lot#1943335); 2% FBS, 2 mM EDTA (Quality
Biological; Cat#51-027-101). The most superficial tissue layers were gently scraped off the underlying abdominal wall using a plastic
cell scraper and forced through a 70 mm cell strainer. Cells were resuspended in buffer containing 25 mM Z-VAD-FMK and stained
with antibodies for CD11b (BioLegend; clone M1/70), I-A/I-E (BioLegend; clone M5/114.15.2) and Ly6G (BioLegend; clone 1A8).
CD45-CD11b+Ly6G- cells were sorted into Dextran+MHCII-CCR2-CX3CR1- (majority of sessile RTM; 85%–90% of CD11b+Ly6G-Cell 177, 541–555.e1–e8, April 18, 2019 e6
cells), MHCII+CCR2+CX3CR1- (migratory tissue monocytes; 10%–15%) and MHCII+CCR2-CX3CR1+ (sessile RTM; 0.5 - 1.5%)
populations, directly into 0.5 mL TRIZOL (Invitrogen; Cat#15596026) using a FACS-Aria cell sorter (BD Bioscience).
RNaseq libraries were prepared using the Nugen Ovation SoLo (NuGEN; Cat#0501-32) with 1 ng total RNA input. Sequencing
was performed using Illumina NextSeq V2 reagents (Illumina; Cat#FC-404-2005) using paired end 75 base pair reads. Samples
were sequenced to a depth of20 million reads. Reads were mapped to theMus musculus mm10 genome build (UCSC annotation)
using Salmon. Salmon-estimated transcripts-per-million (TPM) values were summarized at the gene level using tximport version
1.4.0 and the org.Mm.eg.db database. Data shown in Figure 4B are pooled from three independent biological replicates.
Generation of Planar Sections or Interactive 3D Models
IVM still images were taken on a Zeiss LSM 710 microscope at the Nyquist sampling rate (‘‘optimal’’ resolution setting in ZEN 2012),
and Huygens Professional (18.04; Scientific Volume Imaging) was used for deconvolution at default parameters. 3D surface models
were generated in IMARIS (Bitplane) using default parameters. Individual models were exported from IMARIS as wrl-files and im-
ported into MeshLab (ISTI-CNR). To generate x/y/z slices of the 3D models, individual planar sections were computed in MeshLab
and exported aswrl-meshes, pseudocolored and assembled as a 3D-model using Photoshop (Adobe), whichwas then exported as a
u3d-file and implemented into a pdf-file using Adobe Acrobat Pro DC. To generate interactive multi-layer 3D models, individual sur-
face models were first simplified in MeshLab for better handling using clustering decimation (at 0.5%), and exported again as wrl-
files. Individual mesh models were imported into Photoshop, assembled, pseudo-colored, exported as u3d-files and inserted into
a .pdf-file using Adobe Acrobat Pro DC.
To view and interact with the multi-layer 3D model in the ‘‘Data File,’’ the .pdf-file needs to be opened with Adobe Acrobat Reader
(http://get.adobe.com/reader/otherversions/), as other pdf-viewers (e.g., Preview on macOS) don’t support this function. Once
opened, click on the model to activate the animation. If prompted, click on ‘‘Trust this document.’’ If the 3D model is not
visible, enable 3D content under ‘‘Preferences > 3D & Multimedia > Enable playing of 3D content.’’ See page 3 of Data S1,
page 2 of Data S2, and Data S3 for visual instructions. For further help and troubleshooting, please visit https://helpx.adobe.com/
acrobat/using/displaying-3d-models-pdfs.html.
To interact with themodel, click next to it and hold to freely rotate (seemovie on page 3 of Data S2 for demonstration). OnMac hold
the < option > and < command > keys and use the scroll function of your mouse to zoom in or out (Windows: hold the < Alt > key and
scroll). The ‘‘Model tree’’ lists the individual parts of the model. Here you can hide different parts by clicking the box, or make parts
transparent by clicking on the part and selecting ‘‘Transparent’’ from the ‘‘Options’’ menu above.
Tissue clearing and whole mount imaging
Micewere sacrificed and immediately perfusedwith 20mL 4%PFAover 15minutes. Diaphragmswere harvested and post-fixedwith
0.5% PFA overnight at 4C. On next day, tissues were washed extensively with PBS, and subsequently stained with Wheat Germ
Agglutinin AF488 (10 mg/ml; ThermoFisher; Cat#W11261) diluted in PBS overnight at room temperature. On next day, excess fluids
were removed and tissues were transferred into freshly prepared Ce3D-clearing medium. Ce3D-clearing medium was prepared as
previously described (Li et al., 2017). In brief, 4 g Histodenz (Sigma-Aldrich; Cat#D2158) were dissolved in 2.75 mL 40% N-Methyl-
acetamide (Sigma-Aldrich; Cat#M26305) and 5 mL Triton X-100 (Sigma-Aldrich; Cat#T8787) on a rotator for 2 hours at 37C.
Diaphragms were transferred into the clearing medium and incubated for 2 days on a tube rotator at room temperature. Next, tissues
weremounted on glass slides and confocal imagingwas performed on an inverted SP8microscope (LeicaMicrosystems) using a 20x
0.75NA objective at a 512x512 resolution at 2.5x optical zoom, with voxel size of 0.45 mm in the lateral and 1.5 mm in the axial
direction.
Assessment of spontaneous cloaking
Frequency of spontaneous cloaking in diaphragm tissues ( = 4.94 per whole diaphragm) was calculated based on confocal imaging
data obtained from cleared whole mount diaphragms of five naive, perfusion-fixed Lyz2Cre/+ tdTomfl/+ mice (mixed sex; 12-16 weeks)
with an average whole tissue volume of 105.7 mm3 and an average number of macrophages of 804,582 per diaphragm.
Frequency of spontaneous cloaking in peritoneal tissues ( = 2.09 per whole peritoneum) was calculated based on multiphoton im-
aging data obtained from eight LysMgfp/gfp mice (mixed sex; 10-16 weeks), which, after perfusion-fixation, were prepared as for intra-
vital imaging to avoid artificial damaging of the tissue. As only RTM in the narrow submesothelial spacewere imaged and counted, the
number of cloaking findings was calculated per area of peritoneal tissue (with an average area of 1314 mm2 of the peritoneum lining
the abdominal wall and an average of 748.352 submesothelial RTM per abdominal peritoneum), neglecting the deeper muscular
tissues.
QUANTIFICATION AND STATISTICAL ANALYSIS
No statistical methods were used to predetermine sample sizes. Statistical analyses were performed with Prism 7 (GraphPad
Software). Results are presented as means ± SEM and exact P values are depicted in the figures. Unpaired Student’s t test
(two-tailed), or one-way or two-way ANOVA tests were performed to compare two or more groups after data were confirmed to
be normally distributed. Where applicable, post hoc multiple comparison tests were performed (Tukey for pairs, Bonferroni fore7 Cell 177, 541–555.e1–e8, April 18, 2019
multiple groups). Paired data from the long-term imaging experiments were analyzed using Wilcoxon matched-pairs signed
rank tests.
DATA AND SOFTWARE AVAILABILITY
The complete set of the RNA sequencing data shown Figure 4B are available in NCBI GEO under accession number GEO:
GSE119870.Cell 177, 541–555.e1–e8, April 18, 2019 e8
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Figure S1. Neutrophils Initiate Swarms at Sites of Inflammatory Neutrophil Cell Death, Related to Figure 1 and Videos S1 and S2
(A) Schematic depiction of the experimental setup for imaging the peritoneal serosa. See Video S1A.
(B) 3D-reconstruction of IVM-still images displaying the anatomical structure of the abdominal wall. Grey = collagen (second harmonics); purple = abdominal
muscle wall (second harmonics); red = blood vessels (70kDa dextran); yellow area indicates submesothelial space. Voxel size was increased x 2 in z dimension for
better visualization. See Video S1B. Scale bar, 50 mm.
(C) Bar graphs showing data obtained from IVM experiments comparing dynamic behavior of LysM+ neutrophils and LysM+ neutrophils labeled in situ with Gr1-
FITC. Unpaired t test; n = > 20 cells per condition; means ± SEM. Data representative of 3 independent experiments.
(D) IVM-still images showing a representative cluster of pre-elicited neutrophils at a microlesion labeled with Ly6G-AF594 in a LysMgfp/+ mouse. Blue = RTM pre-
labeled with dextran; Green = LysM. Data representative of 3 independent experiments. Scale bar, 50 mm.
(E) IVM-sequence of RTM and neutrophils (magenta = LysM) responding to Salmonella bacteria (white) topically applied on the peritoneal serosa. Cyan outlines =
Neutrophil swarms. Sequence representative of 3 independent experiments. Scale bar, 100 mm. See Video S2A.
(F) Representative (n > 5) IVM-sequence showing a leading neutrophil (magenta = Gr1) undergoing terminal activation upon contact with tissue debris
(gray = autofluorescence). Terminal activation pattern indicated by characteristic vesicle expulsion (white arrows) and nuclear uptake of propidium iodide (red;
white asterisk). Scale bar, 5 mm.
(G) Schematic depicting the terminal activation pattern of a leading neutrophil upon contact with exposed tissue debris.
(H) Distance-time plot showing examples of tracks of exploratory (left) versus swarming dynamics (right) of extravascular neutrophils migrating toward tissue
damage (bottom of the graph). Track color = chemotactic index.
(I) IVM-sequence showing the death (cyan outline) of a leading neutrophil (magenta = LysM) upon contact with an individual bacterium (magenta; white arrow) and
subsequent swarming dynamic of recruited neutrophils. Sequence representative of 3 independent experiments. Scale bar, 15 mm. See Video S2D.
Figure S2. Neutrophils Undergo Cell Death upon Direct Contact with Debris, Related to Figure 1, Video S2, and Data S1
(A) Representative 3D projection of a stromal microlesion in the submesothelial space of the peritoneal wall, highlighting the acellular anatomical structures.
Scale bar, 5 mm.
(B) IVM-sequence showing a laser-induced microlesion (red = autofluorescence) as corresponding to damage (white arrow) of one individual fibroblast
(blue = CD34). White = LysM. Scale bar, 20 mm.
(C) Representative (n = 5) IVM-sequence showing a partially laser-damaged stromal cell in higher magnification. Blue = isolated fibroblast (CD34);
Orange = Cellular damage. Scale bar, 10 mm.
(D) Schematic comparing features of macro- and microlesions.
(E) Representative (n = 3) IVM-still images (top = max intensity projection; bottom = 3D surface reconstruction) showing a leading neutrophil (magenta = Gr1)
making physical contact with exposed stromal debris (red arrow; orange = autofluorescence) and undergo death. Leading neutrophil in contact with the affected
stromal cell (blue = CD34) but not with the exposed debris fails to undergo terminal activation (white arrow). See Data S1A for interactive 3D model.
Scale bar, 20 mm.
(F) Representative (n = 3) IVM-still images (top = max intensity projection; bottom = 3D surface reconstruction) showing a leading neutrophil (magenta = Gr1)
attempting to make physical contact with stromal debris (orange = autofluorescence) by squeezing a cellular process through a narrow stromal opening
(blue = CD34). See Data S1B for interactive 3D model. Scale bar, 20 mm.
(G) Representative (n > 5) IVM-still image showing the death of a leading neutrophil (magenta = Gr1) upon contact with a microlesion (gray). Scale bar, 10 mm. See
Video S2F.
(H) Individual cell tracks (top) or their respective displacements (bottom) of pre-recruited neutrophils swarming at amacro- (cyan) or amicrolesion (red). Big panels
show overlaid tracks or displacements. Yellow circles indicate injuries. Tracking data representative of 3 independent experiments.
(legend continued on next page)
(I) Representative (n = 3) IVM-sequence (top = max intensity projection; bottom = 3D surface reconstruction) showing swarming of pre-recruited neutrophils
(magenta = Gr1) at a stromal microlesion (gray/orange = autofluorescence) and collateral stromal damage indicated by loss of CD34+ fibroblasts (white outline).
Scale bar, 10 mm.
(J) Individual cell tracks (top) or their respective displacements (bottom) of pre-recruited (magenta) or endogenously recruited neutrophils (green) at amicrolesion.
Big panels show overlaid tracks or displacements. Yellow circles indicate injuries. Tracking data representative of 3 independent experiments.
(legend on next page)
Figure S3. RTM Population Dynamics Determine Cloaking Capacity, Related to Figures 2 and 3 and Video S3
(A) Representative (n > 5) confocal overview image showing RTM (green = CD169) embedded in a stromal tissue network (blue = CD34). Scale bars, 100 mm (top)
and 20 mm (bottom). See Data S2A for interactive 3D model.
(B) Confocal microscopy image showing an individual tissue-resident macrophage after iv-injection of differentially labeled particles. White = CD169;
Purple = BSA; Green = 2000 kDa Dextran; Red = 70 kDa Dextran; Blue = 10 kDa dextran. Scale bar, 5 mm.
(C) Representative confocal microscopy image of the peritoneum from aCx3cr1gfp/+Ccr2rfp/- reporter mouse, showing RTM expressing CD169 (white) in contrast
to migratory CCR2+ monocytes (red). CX3CR1+ cells account for ca. 1%–2% of all sessile RTM in the submesothelial peritoneum. Scale bar, 20 mm.
(D) RTM (blue = LysM) in LysM-tomato CD169-DTR mice before (left) and after RTM-depletion (right). Scale bar, 100 mm. Images representative of > 5 different
experiments.
(E) Compilation of the different monocyte/macrophage depletion regimens used in this study (right) compared to their respective controls (left). Flow cytometry
plots show neutrophil (green) and monocyte (red) populations pre-gated on Singlets+Live+CD45+CD11b+ cells. Microscopy images show CD169 staining of
diaphragm and/or peritoneum tissues. Scale bar, 200 mm. Data representative of > 5 different experiments.
(F) Bar graphs showing monocyte percentages in peripheral blood upon different depletion regimens. n = 5. Means ± SEMs.
(G) Representative (n = 5) confocal images (top =max intensity projection; bottom = individual spot visualization) showing neutrophils (magenta = Ly6G) recruited
into the peritoneal tissues 12 hours after challenge of CD169-DTR mice pre-treated with vehicle (left; green) or DT (right; magenta) with 10 mg zymosan i.p..
Scale bar, 500 mm. Data representative of 2 independent experiments. Means ± SEMs.
(H) Individual cell tracks (left) or their respective displacements (right) of endogenously recruited neutrophils at a microlesion in CD169-DTR mice treated with
vehicle (green) or DT (magenta). Big panels show overlaid tracks or displacements. Tracking data representative of 5 independent experiments. See Figure 3B.
(I) Representative IVM-still image and histogram of GFP intensity (mean fluorescence intensity, MFI) showing how to distinguish LysM-expressing RTM and
neutrophils, based on GFP intensity, dextran uptake and in situ anti-Gr1 labeling. Scale bar, 10 mm.
(J) Individual track displacements of endogenously recruited neutrophils migrating toward a cloaked (left lesion 1) or an un-cloaked (right lesion 2) microlesion.
Tracking data representative of 3 independent experiments. See Video S4B.
(K) Schematic depicting the experimental setup of partially replacing host RTM by adoptively transferring donor bone marrow into a LysMCre/+Csfr1LsL-DTR/+ host
after depleting monocytes and macrophages. Successful transfer generates donor/host-chimerism of monocyte-derived RTM in the peripheral tissues.
(L) Simplified schematic of the experimental setup for partially replacing host RTM (red) with adoptively transferred bone marrow isolated from LysM-tomato
(cyan) or LysM-gfp (yellow) mice.
(M) Left: Representative (n = 3) confocal microscopy image showing recovered/replaced RTM populations of host- (red) or donor-derived origin (yellow & cyan)
after RTM-depletion and adoptive monocyte/precursor transfer as described in (B). Scale bar, 300 mm. Right: IVM-still image of donor-derived RTM cloaking a
microlesion after adoptive transfer. Scale bar, 20 mm.
(N) Schematic of the experimental setup for partially replacing host RTM with adoptively transferred bone marrow isolated from LysM-tomato animals to create
chimerism of DTR-positive (host) and DTR-negative (donor) RTM. Subsequent DT-retreatment then generates RTM-rich and -depleted areas within the same
tissue. See Figure 3F.
(O) IVM-still images after DT-retreatment on day 56 after adoptive monocyte transfer as described in (N). Red color indicates dextran-uptake by remaining donor-
derived RTM (green = LysM) after DT-retreatment. Scale bar, 30 mm. Data representative of 3 independent experiments. See Figure 3F.
(P) Schematic depicting the relationship between macrophage density, size and lesion count, and the likelihood of neutrophil swarming versus successful
cloaking.
Figure S4. Dynamic Responses of Monocytes and RTMs to Sterile Tissue Damage, Related to Figures 4 and 5 and Videos S3 and S5
(A) Schematic mean square displacement plots illustrating the different modes of movement (blue = targeted; magenta = confined) depicted in Figures 4A and 4F.
(B) Schematic depicting the biphasic dynamic cloaking response: an initial ‘‘sensing’’ phase comprises the activation on macrophages within 200 – 250 mm of a
lesion, which is subsequently followed by ‘‘convergence’’ of pseudopods around the damage. See Video S3C and compare with Figure 2C.
(C) Representative (n = 3 with 2-3 microlesions per experiment) IVM-still images showing peritoneal tissue 30 minutes after damage induction in RAGE/.eGFP
mice. Successful RAGE-deletion results in strong eGFP expression in all RAGE-expressing immune and non-immune cells (left). eGFP-signal in RTMwas isolated
by staining for CD88 on macrophages in situ (right). Scale bar, 20 mm. White circle mark un-cloaked parts of the damage.
(D) Schematic of the experimental setup for partially replacing host RTM with adoptively transferred bone marrow isolated from wild-type LysM-reporter
(RAGE+/+) or RAGE-deficient (RAGE/.eGFP) mice to create chimerism of RAGE+/+ and RAGE / RTM within the same tissue. See Figures 4H and 4I.
(E) Relative recruitment dynamics of endogenous neutrophils (magenta) and monocytes (blue) to macrolesions. Data pooled from 3 independent experiments.
(F) IVM-sequence of the dynamic behavior of CCR2+ migratory monocytes (yellow; white tracking lines) under resting conditions (1) and in response to a
microlesion (2; yellow outline). Data representative of 3 independent experiments. Scale bar, 20 mm. See Video S5A.
Figure S5. RTMs Prevent Inflammatory Myopathy, Related to Figures 6 and 7 and Video S6
(A) Representative (n = 3 for each tissue) confocal images showing RTM (green = LysM) in the liver capsule, pericardium and diaphragm tissue. Scale bar, 100 mm.
Sagittal section of a mouse brain with focus on microglia (green = CX3CR1-gfp) in the cortical region. Scale bars, 1000 mm (whole brain) and 500 mm (top).
(legend continued on next page)
(B) Bar graphs showing representative (n = 3 for each tissue) cell-cell-distance between RTM or migratory monocytes or peritoneal stroma cells. Two-way
ANOVA; means ± SEM.
(C) Bar graphs showing representative (n = 3 for each tissue) Nearest-Neighbor-Index NNI for the different RTM populations in various tissues or migratory
monocytes or peritoneal stroma cells. An NNI > 1 indicates uniform distribution; NNI < 1 indicates clustered distribution; NNI = 1 indicates random distribution.
Two-way ANOVA; means ± SEM.
(D) Representative IVM- sequence (top = max intensity projection; bottom = 3D surface reconstruction) showing laser-induced partial damage (orange =
autofluorescence) of a myocyte (purple = second harmonics). Scale bar, 10 mm.
(E) Representative IVM-sequence (top = max intensity projection; bottom = single slice through plane of damage) showing characteristic morphological changes
after partial laser-induced damage (orange = autofluorescence) of a myocyte (eCFP) in neutrophil-depleted (1A8) CAG-eCFP-reporter mice. Red arrow indicates
lesion with local loss of striation and CFP signal. Yellow arrows indicate local swelling. White arrows show local emergence of longitudinal striation in damaged
area. Scale bars, 50 mm (top) and 20 mm (bottom and right).
(F) Representative IVM-sequence (top = max intensity projection; bottom = 3D surface reconstruction) showing pre-recruited neutrophils (magenta = Gr1)
swarming at a partially damaged myocyte (purple = second harmonics) microlesion (orange = autofluorescence). Red arrows and white outline show ruptured
muscle fiber. Scale bar, 20 mm. Data representative of 3 independent experiments.
(G) Schematic explaining themeasurement of the distance between the center of the nucleus and the tip of the furthest pseudopod of cloaking (top) versus resting
macrophages (bottom). Scale bars, 20 mm. Top graph shows nucleus-pseudopod distances of resting RTM versus RTM cloaking a stromal or muscular lesion or
in young mdx mice (day 14). Unpaired t test; means ± SEM. Middle graph shows paired average nucleus-pseudopod distances from 3 independent experiments
for each condition. Paired t test; means ± SEM. Bottom graph shows average nucleus-pseudopod (NyP) distance ratios of cloaking (green) versus non-cloaking
(white) macrophages.
(H) Representative confocal microscopy image showing close association of infiltrating neutrophils (magenta = Ly6G) with necrotic muscle fibers (blue = Evans
blue staining of necrotic tissue) in mdx mice at day 18 after birth. Scale bar, 10 mm
(I) Representative images of diaphragm whole mounts frommdxmice on day 16 after birth, treated with isotype (left) or aCSF1R (right). Arrows indicate necrotic
tissues (orange-to-white = Evans blue staining of necrotic tissue). Scale bar, 1000 mm. n = 5 mice per group. See Figure 7B.
(J) Representative images of diaphragm whole mounts frommdx mice on day 18 after birth, treated with isotype (left) or aCSF1R (right). Arrows indicate necrotic
tissues (orange-to-white = Evans blue staining of necrotic tissue). Scale bar, 1000 mm. n = 5 mice per group. See Figure 7B.
(K) Representative image of diaphragm whole mount from mdx mice on day 18 after birth treated with aLy6G and aCSF1R. Arrows indicate necrotic tissues
(orange-to-white = Evans blue staining of necrotic tissue). Scale bar, 1000 mm. n = 3 mice per group. See Figure 7B.
(L) IVM-still image after perfusion fixation showing spontaneously cloaking RTM (green = LysM) in naive, unchallenged mice. Scale bar, 30 mm.
(M) Representative images (n = 3) of peritoneal tissues from adult CD169-DTR mice after long-term treatment with DT. Orange-to-white = Evans blue staining of
necrotic tissue). Scale bar, 500 mm.
(N) Schematic depiction of the proposed mechanism. Left: Sufficient cloaking of microlesions prevents the contact activation of leading neutrophils by blocking
physical access to the lesion and removal of pro-inflammatory debris, thereby preventing the initiation of swarming and inflammation. Right: Insufficient cloaking
allows the leading neutrophil to make physical contact with the debris, undergo terminal activation and inflammatory cell death, which subsequently recruits and
activates more neutrophils, and initiates neutrophil swarming. See also Video S6.
